Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats

References

• EskowKLDupreKBBarnumCJDickinsonSOParkJYBishopCThe role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian ratsSynapse200963761062019309758
   PubMed Web of Science ®Google Scholar
• JaunarajsKLDupreKBSteinigerASerotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesiaNeuroreport200920141265126919633584
   PubMed Web of Science ®Google Scholar
• CartaMCarlssonTKirikDBjörklundADopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian ratsBrain2007130Pt 71819183317452372
   PubMed Web of Science ®Google Scholar
• JennerPPreventing and controlling dyskinesia in Parkinson’s disease – a view of current knowledge and future opportunitiesMov Disord200823Suppl 3S58559818781676
   PubMed Web of Science ®Google Scholar
• BjörklundTCarlssonTCederfjällEACartaMKirikDOptimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s diseaseBrain2010133Pt 249651120129936
   PubMed Web of Science ®Google Scholar
• StocchiFThe therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s diseaseParkinsonism Relat Disord200915Suppl 3S687120083012
   PubMedGoogle Scholar
• RenTYangXWuNCaiYLiuZYuanWSustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned ratsNeurosci Lett2011502211712221835223
   PubMed Web of Science ®Google Scholar
• LebelMChagnielLBureauGCyrMStriatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian ratNeurobiol Dis2010381596720060905
   PubMed Web of Science ®Google Scholar
• PaxinosGWatsonCThe Rat Brain in Stereotaxic Coordinates6th edSydney, AustraliaAcademic Press2007
   Google Scholar
• MorgeseMGCassanoTCuomoVGiuffridaAAnti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB(1) and TRPV1 receptorsExp Neurol2007208111011917900568
   PubMed Web of Science ®Google Scholar
• KimDSPalmiterRDCumminsAGerfenCRReversal of supersensitive striatal dopamine D1 receptor signaling and extracellular signal-regulated kinase activity in dopamine-deficient miceNeuroscience200613741381138816388913
   PubMed Web of Science ®Google Scholar
• SmithLAJacksonMJAl-BarghouthyGMultiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primatesMov Disord200520330631415490461
   PubMed Web of Science ®Google Scholar
• LindgrenHSOhlinKECenciMADifferential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson’s diseaseNeuropsychopharmacology200934122477248819606087
   PubMed Web of Science ®Google Scholar
• SantiniEValjentEUsielloACritical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesiaJ Neurosci200727266995700517596448
   PubMed Web of Science ®Google Scholar
• SantiniEAlcacerCCacciatoreSL-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian miceJ Neurochem2009108362163319187092
   PubMed Web of Science ®Google Scholar
• PavónNMartínABMendialduaAMoratallaRERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian miceBiol Psychiatry2006591647416139809
   PubMed Web of Science ®Google Scholar
• WestinJEVercammenLStromeEMKonradiCCenciMASpatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptorsBiol Psychiatry200762780081017662258
   PubMed Web of Science ®Google Scholar
• IravaniMMJennerPMechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulationJ Neural Transm2011118121661169021881839
   PubMed Web of Science ®Google Scholar
• RavenscroftPChalonSBrotchieJMCrossmanARRopinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson’s disease: implications for dyskinesiaExp Neurol20041851364614697317
   PubMed Web of Science ®Google Scholar
• MarinCBonastreMAguilarEJiménezAThe metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl) pyridine decreases striatal VGlut2 expression in association with an attenuation of L-dopa-induced dyskinesiasSynapse201165101080108621484883
   PubMed Web of Science ®Google Scholar
• LevandisGBazziniEArmenteroMTNappiGBlandiniFSystemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson‘s diseaseNeurobiol Dis200829116116817933546
   PubMed Web of Science ®Google Scholar
• YamamotoNSoghomonianJJMetabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned ratsNeuroscience200916341171118019660528
   PubMed Web of Science ®Google Scholar
• GreengardPThe neurobiology of slow synaptic transmissionScience200129455441024103011691979
   PubMed Web of Science ®Google Scholar
• KuanWLZhaoJWBarkerRAThe role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson‘s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopramPsychopharmacology (Berl)2008197227929318157704
   PubMed Web of Science ®Google Scholar
• CalabresiPDi FilippoMGhiglieriVPicconiBMolecular mechanisms underlying levodopa-induced dyskinesiaMov Disord200823Suppl 3S57057918781674
   PubMed Web of Science ®Google Scholar
• AubertIGuigoniCHåkanssonKIncreased D1 dopamine receptor signaling in levodopa-induced dyskinesiaAnn Neurol2005571172615514976
   PubMed Web of Science ®Google Scholar
• BovéJSerratsJMengodGCortésRAguilarEMarinCReversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned ratsSynapse200659743544416498608
   PubMed Web of Science ®Google Scholar
• TamimMKSamadiPMorissetteMEffect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptidesNeuropharmacology201058128629619576910
   PubMed Web of Science ®Google Scholar